Day Zero Diagnostics
Brookline, US · Founded 2016 · 3 known investors
Find your way into Day Zero Diagnostics
Sign up to see every warm intro you have to Day Zero Diagnostics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Day Zero Diagnostics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
The page is a bioMérieux blog article about tracking a Cyclospora cayetanensis outbreak in the United States, referencing its clinical diagnostic and wastewater surveillance products for community health and medical professionals.
Founders & leadership
Day Zero Diagnostics was founded in 2016 by Jong Lee, Miriam Huntley, and Douglas Kwon.

Board
Investors · 3
How we know: Golden Seeds's portfolio page · a partner's Signal profile · Not right? Tell us
How we know: a partner's Signal profile · the VCSheet dataset · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements$2.5M disclosed across 1 of 5 rounds · 2017–2023
- Undisclosed amountSeries AJan 2019 · 2 sourcesSource ↗
▶$2.5MraisedMay 2017 · 28 investors · BiotechnologyRule 506(b)
- Jong LeeExecutive Officer, Director
- Jeff MirvissDirector
- Miriam HuntleyExecutive Officer
- Dougal MclaurinExecutive Officer
- Laura DavisDirector
- Douglas KwonDirector
- Offering amount
- $3.5M
- Amount sold
- $2.5M
- First sale
- May 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 4 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $300K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $303.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $300K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $224.4K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Day Zero Diagnostics do?
- The page is a bioMérieux blog article about tracking a Cyclospora cayetanensis outbreak in the United States, referencing its clinical diagnostic and wastewater surveillance products for community health and medical professionals.
- Who founded Day Zero Diagnostics?
- Day Zero Diagnostics was founded by Jong Lee, Miriam Huntley, Douglas Kwon in 2016.
- Who are Day Zero Diagnostics's investors?
- Day Zero Diagnostics's investors include Golden Seeds, Triventures.
- How much funding has Day Zero Diagnostics raised?
- Day Zero Diagnostics has disclosed $2.5M raised across 1 of its 5 known rounds.
- Where is Day Zero Diagnostics headquartered?
- Day Zero Diagnostics is headquartered in Brookline, US.